Adaptam Therapeutics
Adaptam’s approach focuses on disrupting the tumour microenvironment, which often prevents immune cells from effectively attacking cancer.
Barcelona, Spainadaptamtx.com ↗
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-10
latest 2025-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood26
base rate 24% for Pre-Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-27 | Pre-Seed | €3.0M | Criteria Bio Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel